Bard Associates Inc. reduced its position in shares of Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 6.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,928,168 shares of the company’s stock after selling 199,337 shares during the quarter. Bard Associates Inc.’s holdings in Modular Medical were worth $1,066,000 at the end of the most recent quarter.
A number of other institutional investors have also added to or reduced their stakes in MODD. Perritt Capital Management Inc raised its stake in Modular Medical by 34.2% during the 3rd quarter. Perritt Capital Management Inc now owns 85,000 shares of the company’s stock worth $59,000 after buying an additional 21,675 shares during the period. Jane Street Group LLC raised its stake in Modular Medical by 446.8% during the 4th quarter. Jane Street Group LLC now owns 163,952 shares of the company’s stock worth $60,000 after buying an additional 133,969 shares during the period. Finally, Bleichroeder LP raised its stake in Modular Medical by 41.9% during the 4th quarter. Bleichroeder LP now owns 2,859,581 shares of the company’s stock worth $1,041,000 after buying an additional 845,000 shares during the period. 27.47% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Modular Medical in a research note on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Modular Medical currently has an average rating of “Sell”.
Modular Medical Price Performance
Shares of NASDAQ MODD opened at $4.77 on Friday. The stock has a market capitalization of $22.23 million, a P/E ratio of -0.32 and a beta of 0.31. The company has a 50-day moving average price of $4.54 and a 200-day moving average price of $8.74. Modular Medical, Inc. has a 1 year low of $3.13 and a 1 year high of $30.00.
Modular Medical Profile
Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
Further Reading
- Five stocks we like better than Modular Medical
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding MODD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Modular Medical, Inc. (NASDAQ:MODD – Free Report).
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
